Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Cells|April 3, 2021
Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood ClotsTatiana A Kovalenko, Marie-Noelle Giraud, Anita Eckly, et al.
Swiss Medical Weekly|May 17, 2021
Coronary and structural heart interventions in Switzerland 2019Max Wagener, Raphael Twerenbold, Stéphane Cook, et al.
Journal of the American College of Cardiology|September 4, 2019
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)Konstantinos C Koskinas, Stephan Windecker, Giovanni Pedrazzini, et al.
Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2017
Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionStephane Fournier, Olivier Muller, Umberto Benedetto, et al.
CJC Open|April 20, 2026
Tricuspid Transcatheter-Edge-to-Edge-Repair and Transcatheter Tricuspid Valve Replacement for Tricuspid Regurgitation: Patient Profiles and OutcomesJulius Jelisejevas, Brian Chiang, Ali Husain, et al.
Swiss Medical Weekly|March 22, 2014
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensusGregoire Wuerzner, Olivier Muller, Paul Erne, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 23, 2015
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarctionThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.
Open Heart|June 18, 2024
Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 yearsFranz R Eberli, Keith G Oldroyd, Philip Urban, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2019
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB TrialChun Chin Chang, Yoshinobu Onuma, Stephan Achenbach, et al.
Pageof 16